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ABSTRACT: QT interval dispersion (QTd) reflects inhomogeneity of repolarisation. Delayed
cardiac repolarisation leading to the prolongation of the QT interval is a well-characterised
precursor of arrhythmias. Obstructive sleep apnoea syndrome (OSAS) can cause cardiovascular
complications, such as arrhythmias, myocardial infarction, and systemic and pulmonary
hypertension. The aim of this study was to assess QTd in OSAS patients without hypertension.
A total of 49 subjects without hypertension, diabetes mellitus, any cardiac or pulmonary
diseases, or any hormonal, hepatic, renal or electrolyte disorders were referred for evaluation of
OSAS. An overnight polysomnography and a standard 12-lead ECG were performed in each
subject. According to the apnoea–hypopnoea index (AHI), subjects were divided into control
subjects (AHI ,5, n520) and moderate–severe OSAS patients (AHI o15, n529). QTd (defined as
the difference between the maximum and minimum QT interval) and QT-corrected interval
dispersion (QTcd) were calculated using Bazzet’s formula.
In conclusion, the QTcd was significantly higher in OSAS patients (56.1¡9.3 ms) than in
controls (36.3¡4.5 ms). A strong positive correlation was shown between QTcd and AHI. In
addition, a significantly positive correlation was shown between QTcd and the desaturation index
(DI). The AHI and DI were significantly related to QTcd as an independent variable using stepwise
regression analysis.
The QT-corrected interval dispersion is increased in obstructive sleep apnoea syndrome
patients without hypertension, and it may reflect obstructive sleep apnoea syndrome severity.
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T
he variability in the QT interval duration
between the different leads of a surface
12-lead ECG reflects local differences
in recovery time of the myocardium [1, 2]. In
addition, QT interval dispersion (QTd) is
increased in patients with a priori myocardial
infarction, who have a susceptibility to ventricu-
lar tachyarrhythmias, most obviously via a re-
entry mechanism [3]. It has been suggested that
increased QTd may be a marker of arrhythmic
risk in patients with impaired left ventricular
function [4].
Obstructive sleep apnoea syndrome (OSAS) is
characterised by repetitive collapse of the upper
airway during sleep [5]. The obstructive apnoeic
event is associated with considerable breathing
efforts against the totally or partially occluded
upper airway. The apnoea is terminated by an
arousal and heavy snoring as airflow is restored.
Severity of OSAS is described according to the
total number of apnoeas and hypopnoeas per
hour of sleep, which is termed the apnoea–
hypopnoea index (AHI).
Cardiovascular disturbances are the most serious
complications of OSAS. These complications
include nocturnal arrhythmias [6], acute myocar-
dial infarction [7], heart failure [8], stroke [9], and
systemic [10, 11] and pulmonary hypertension
[12]. All of these cardiovascular complications
increase the morbidity and mortality of OSAS.
Sleep apnoea is currently accepted as one of the
identifiable causes of hypertension, as described
in the JNC 7 report [13].
The aim of the present study was to assess QTd in
OSAS patients without hypertension.
METHODS
Study population
Ninety-six subjects were admitted to a sleep
clinic with nocturnal snoring and/or excessive
AFFILIATIONS
Depts of *Cardiology, and
#Chest Disease, Pamukkale
University Medical Faculty, Denizli,
Turkey.
CORRESPONDENCE
D. Dursunoglu
Yunus Emre Mah. 6402 sk. No: 12
Kınıklı – Denizli
Turkey
Fax: 90 2582134922
E-mail: ddursunoglu@tnn.net/
ddursunoglu@pamukkale.edu.tr
Received:
June 07 2004
Accepted after revision:
December 23 2004
European Respiratory Journal
Print ISSN 0903-1936
Online ISSN 1399-3003
EUROPEAN RESPIRATORY JOURNAL VOLUME 25 NUMBER 4 677
Eur Respir J 2005; 25: 677–681
DOI: 10.1183/09031936.05.00067104
CopyrightERS Journals Ltd 2005
c
daytime symptoms, and a detailed sleep and cardiovascular
anamnesis of the patients was recorded. Sleep cycle, nutritional
status, medications, alcohol usage and family anamnesis were
also established. All patients were asked questions from the
Epworth sleepiness scale (ESS) [14], and patients with high
scores (ESS o10) were accepted into the sleep study.
A physical examination was performed on all subjects. Systolic
(BPs) and diastolic (BPd) blood pressures were measured in the
sitting position from the right arm using a sphygmoman-
ometer (Erka, Bad Tölz, Germany), after o5 min of rest. Heart
rate per minute (HR) was measured in the sitting position, and
the body mass index (BMI) of each patient was calculated as
weight divided by height squared (kg?m-2). After an overnight
fast (o12 h), routine biochemical parameters (e.g. blood
glucose, lipids, urea, creatinine, electrolytes, hepatic enzymes)
were analysed using commercial kits (Abbott Laboratories,
Abbott Park, IL, USA) by an autoanalyser (Aeroset; Abbott
Laboratories).
Pulmonary function tests (SensorMedics 2400; SensorMedics,
Bilthoven, The Netherlands) and arterial blood gas analysis
(ABL 30; Radiometer, Copenhagen, Denmark) were performed
in all patients at rest. In the morning, a 12-lead surface ECG
was taken from every subject: all were in sinus rhythm, and no
subjects had intraventricular conduction delay or a prolonged
QRS complex, which would thereby increase the QT interval.
In addition, all of subjects underwent treadmill exercise
testing, which was normal for each subject. None of the
subjects was taking medications that could potentially prolong
the QT interval.
To be eligible, none of the 96 subjects was permitted to suffer
from: 1) any known cardiac or pulmonary disease; 2) hyper-
tension (blood pressure .140/90 mmHg or taking antihyper-
tensive therapy); 3) diabetes mellitus or impaired glucose
tolerance (fasting blood glucose .110 mg?dL-1 or taking
antidiabetic therapy); 4) angina pectoris; 5) bundle branch
block, atrial fibrillation, any arrhythmias or fewer than six
measurable leads in the resting ECG; 6) chronic renal or
hepatic diseases (by both self-report and serum analysis); or 7)
serum electrolytes imbalances.
Polysomnography
Polysomnography [15] was applied to all subjects during the
diagnostic night. The portable, limited sleep study, performed
with an Embletta device [16], consisted of the following: 1)
nasal pressure detection using a nasal cannulae/pressure-
transducer system, which recorded the square root of pressure
as an index of flow; 2) thoraco-abdominal movement detection,
via two piezoelectric belts; 3) finger pulse oximetry; and 4)
body position detection.
An apnoea was defined as total obstruction of oronasal airflow
for o10 s, a hypopnoea was defined as a decrease of airflow of
o50% and desaturations were accepted as a o4% decrease
in oxygen saturation [17]. The desaturation index (DI) was
identified as the number of oxygen desaturation events per
hour of sleep. Subjects with an AHI o5 were diagnosed as
OSAS [18]. According to the AHI, subjects were divided into
two groups: 1) control subjects (AHI ,5, n520); and 2) patients
with moderate–severe OSAS (AHI o15, n529). There were no
mild OSAS (AHI 5–15) patients in the study population.
Measurement of QT interval and dispersion
In the morning, after o10-min rest in the supine position, a 12-
lead ECG was recorded at a paper speed of 50 mm?s-1 on a six-
channel recorder. Two consecutive cycles were measured from
each of the standard 12 leads and, subsequently, a mean QT
was calculated from the two values. The QT intervals were
manually measured from the onset of the QRS to the end of the
T-wave, defined as the return to TP isoelectric baseline, by a
tangential method [3]. Only monophasic well-defined T-waves
were accepted for measurement. When U-waves were present,
the QT was measured to the nadir of the curve between the
T and U waves, with the aid of a tangent. If the end of the
T-wave could not be reliably determined, or if T-waves were
isoelectric or of very low amplitude, the lead was not included
in the analysis. A minimum of six leads, at leads three
precordial, was required for inclusion in the study. The
measurements were performed manually by an experienced
observer blinded to the clinical data of the patients. The QTd
was defined as the difference between the maximum and
minimum QT values, and the mean value of two consecutive
cycles was calculated. Bazett’s formula was used to obtain HR-
corrected (c) values of the QT intervals and dispersions [19], as
follows:
QTc~QT=HRR ð1Þ
To estimate the intra-observer variability, two photocopies of a
random sample of 10 ECGs were taken and the QT interval
was measured again. The relative difference (mean absolute
difference in percentage of mean measured value) was 1.5% for
the QT interval and 4.2% for the QTd.
Statistical analysis
Results are presented as mean¡SD and the Mann-Whitney U-
test was used to compare the two groups. Stepwise regression
analysis was used to identify possible determinants of QT-
corrected interval dispersion (QTcd). The correlations among
QTcd and the variables of OSAS severity were investigated by
Pearson correlation analysis. A p-value ,0.05 was considered
statistically significant.
RESULTS
A total of 27 males and 22 females were included the study.
None of them was using alcohol and 45% of them smoked
cigarettes. The mean ESS score of the study population was
16.8¡6.1 (range 10–24). Basic characteristics and QTcd of the
moderate–severe OSAS patients and controls are shown in
table 1. There were no significant differences between moder-
ate–severe OSAS patients and controls according to sex, age,
BMI, BPs, BPd and HR (p.0.05). AHI and DI were significantly
higher in moderate–severe OSAS patients than in controls
(p,0.0001), although, in contrast, these patients had the lowest
average and minimum nocturnal saturation of arterial oxygen
(Sa,O2; p,0.0001). The percentage of sleep duration where Sa,O2
was ,90% was highest in the OSAS patients, whereas it was
lowest in controls.
The QTcd was significantly higher in moderate–severe OSAS
patients (56.1¡9.3 ms) than in controls (36.3¡4.5 ms;
p,0.001). A strong positive correlation was shown between
QTcd and AHI, reflecting the severity of OSAS (p,0.001,
r50.954). Correlation between QTcd and AHI in OSAS patients
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without hypertension is shown in figure 1. In addition, a
significant positive correlation was shown between QTcd and
DI (r50.485, p,0.01). However, statistically negative correl-
ations were found between QTcd and minimum nocturnal Sa,O2
(r5-0.494, p,0.05) and average nocturnal Sa,O2 (r5-0.452,
p,0.05).
In OSAS patients, multiple regression analysis was performed
to evaluate the relationships described previously when the
effects of confounding factors such as age, BMI, HR, BPs and
BPd were taken into account, although all of these factors were
not significantly different between moderate–severe OSAS
patients and controls. The AHI (R250.25, p50.0001), DI
(R250.22, p50.0001), minimum and average nocturnal Sa,O2
(%; R25-0.20, p50.002 and R25-0.18, p50.002, respectively)
were significantly related to the QTcd as independent variables
using stepwise regression analysis.
DISCUSSION
QTd has been shown to be a useful noninvasive method for the
detection of inhomogeneity of ventricular recovery times [1, 2].
In addition, experimental studies provide powerful evidence
for the significance of the dispersion of myocardial recovery
times in respect to the occurrence of ventricular arrhythmias
[20, 21]. However, there are some problems when trying to
achieve an accurate measurement of the QT interval [22]: low
T-wave amplitude and the presence of the U-wave create
difficulties in identifying the end of the T-wave. Careful
selection of the leads from which the T-wave can reliably be
identified is required.
It has been proposed that the inter-lead differences in
ventricular recovery time could be due to technical artefacts,
such as differential tissue attenuation or differences in unipolar
versus bipolar leads. DAY et al. [23] have suggested that the QTd
could be affected by the number of measurable leads. In the
current study, it was found that the number of evaluable leads
was, on average, 10.
Recovery time dispersion has been studied using both invasive
and time-consuming methods, such as monophasic action
potentials [24] or body surface mapping [25], respectively.
QTcd is preferable to QTd when simultaneous 12-lead record-
ing is not available, and inter-lead variations in cycle length
could introduce errors in calculation.
The current authors have previously used Bazett’s formula [19]
for calculation of QTc. To evaluate and compare QTc formulae
in 21 healthy subjects, MOLNAR et al. [26] used 24-h Holter
monitoring, as it allows the assessment of QT intervals over a
large range of rates. QT–RR relationships for individuals and
the group were fitted by regression analysis to five QT
prediction formulas: simple Bazett’s, modified Bazett’s,
linear (Framingham), modified Fridericia’s and exponential
(Sarma’s). It was shown that there were no significant
differences in mean squared residuals between formulae.
When using individually calculated regression parameters,
each formula gave good or acceptable QTc over the entire
range of RR intervals. The simple Bazett’s formula, which uses
no regression parameters, was unreliable at high rates. When
group-based regression parameters were applied to individ-
uals, no formula had a clear advantage over simple Bazett’s. It
was concluded that any formula that invokes regression
parameters unique to each individual provides satisfactory
QTc. When individual parameters cannot be determined, as in
a 12-lead ECG, no formula provides an advantage over the
familiar simple Bazett’s.
The present study showed that QTcd is increased in patients
with moderate–severe OSAS when compared with controls. In
TABLE 1 Basic characteristics and QT-corrected interval
dispersion (QTcd) in moderate–severe obstructive
sleep apnoea syndrome (OSAS) patients and
controls
Controls (AHI ,5) OSAS (AHI o15) p-value#
Subjects n 20 29
Male 11 (55) 16 (55) NS
Female 9 (45) 13 (45) NS
Age yrs 45.0¡4.6 45.8¡5.1 NS
BMI kg?m-2 28.3¡3.4 29.7¡3.1 NS
BPs mmHg 111.0¡8.0 118.2¡7.7 NS
BPd mmHg 74.5¡3.3 78.4¡4.2 NS
HR beats?min-1 78.3¡8.1 79.5¡10.0 NS
AHI per hour 3.2¡1.6 42.4¡17.6 ,0.0001
DI per hour 9.6¡4.7 31.5¡17.1 ,0.0001
Min. Sa,O2 % 84.8¡5.7 73.9¡13.8 ,0.0001
Average Sa,O2 % 94.1¡3.2 80.1¡9.0 ,0.0001
Sleep duration
Sa,O2 ,90% %
1.5 53.6 ,0.0001
QTcd ms 36.3¡4.5 56.1¡9.3 ,0.001
Data are presented as n (%) or mean¡SD, unless otherwise stated. AHI:
apnoea–hypopnoea index; BMI: body mass index; BPs: systolic blood
pressure; BPd: diastolic blood pressure; HR: heart rate; DI: desaturation index;
min.: minimum; Sa,O2: nocturnal arterial oxygen saturation.
#: using the Mann-
Whitney U-test. NS: nonsignificant.
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FIGURE 1. Correlation between QT-corrected interval dispersion (QTcd) and
apnoea–hypopnoea index (AHI) in obstructive sleep apnoea patients without
hypertension. R50.954; p,0.01.
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previous studies, QTd has been shown to be increased in
patients after acute myocardial infarction [3], and in patients
with chronic heart failure [4], long QT syndrome [27] and
hypertrophic cardiomyopathy [28].
OSAS is closely associated with obesity [29] and ageing [30]. A
strong relationship between systemic hypertension and OSAS
has been indicated in some epidemiological studies [10, 11, 31–
33] and, presently, sleep apnoea is accepted as one of the
identifiable causes of hypertension, as shown in the JNC 7
report [13]. It is well known that the risk of developing
systemic hypertension increases depending on the severity of
OSAS [34]. In addition, strong relationships have been
established between the severity of systemic hypertension
and AHI, DI and minimum nocturnal Sa,O2 in several studies
[33, 35]. In addition, it has been suggested that blood pressure
decreases when the treatment of OSAS is optimal [36]. In the
current study, the proportion of sleep time where Sa,O2 was
,90% was highest in the OSAS patients, whereas it was the
lowest in the controls. Therefore, the moderate–severe OSAS
patients had longer periods of hypoxia during sleep than
control subjects. In the present study, the presence of systemic
hypertension, diabetes mellitus and coronary artery disease in
patients was excluded, and there were no significant differ-
ences in sex, age, BMI and arterial blood pressure between
subjects. Thus, the QTcd was assessed in uncomplicated
(isolated) patients with OSAS. In addition, positive correlations
were found between QTcd, and AHI and DI, reflecting the
severity of OSAS (r50.954, p,0.001 and r50.485, p,0.01,
respectively). AHI (R250.25, p50.0001) and DI (R250.22,
p50.0001) were also significantly related to the QTcd, as
independent variables, using stepwise regression analysis.
However, there were statistically negative correlations
between QTcd, and minimum and average nocturnal Sa,O2
(r5-0.494, p,0.05 and r5-0.452, p,0.05, respectively) as
expected. Therefore, it might be suggested that increased
QTcd in OSAS patients is related to the severity of OSAS and,
thus, to hypoxaemia.
Although arrhythmic susceptibility was not assessed in the
patients with OSAS, the present observations suggest that
degree of AHI is significantly associated with increased
inhomogeneity in repolarisation (r50.954, p,0.001), probably
predisposing the patients to life-threatening arrhythmias.
Several studies have investigated the prevalence of nocturnal
arrhythmias in patients with OSAS [6, 37, 38]. Two were
prospective studies, which followed-up consecutive referrals
and included a control group: the prevalence of arrhythmias in
these prospective studies was similar to that observed in
healthy adults [37, 38]. The study with the most valid
measurement and classification of arrhythmias found no
difference between the groups [37].
In this study, the reasons for increased QTcd in patients with
OSAS compared with controls have not been clarified. Altered
autonomic cardiac control is known to predispose individuals
to ventricular arrhythmias under several experimental and
clinical conditions [39, 40]; increased sympathetic and/or
reduced vagal tone may facilitate arrhythmogenesis by a re-
entrant mechanism, triggered activity and increased automa-
ticity. In the future, this may be confirmed if HR variability in
patients with OSAS is investigated in longitudinal studies.
Conclusion
The present study demonstrates that increased AHI and DI in
patients with OSAS may result in inhomogeneity of repolar-
isation, favouring a propensity towards ventricular tachy-
arrhythmias. A significant positive correlation was found
between repolarisation inhomogeneity (QTcd) and severity of
OSAS (AHI). In the future it will be important to establish
whether repolarisation inhomogeneity may be corrected by
continuous positive airway pressure treatment aimed at
reducing upper airway obstruction in patients with OSAS.
Study limitation
This study is affected by fundamental limitations in the use of
QT interval and QT dispersion measurements. For comparison
with other studies, the QT interval was corrected for heart rate.
It is well known that Bazett’s formula is inaccurate at higher
heart rates [26]. It overcorrects at faster heart rates and
undercorrects at lower heart rates. In addition, there were
only a small number of patients in the present study
population, which is an important study limitation.
Furthermore, the sleep clinic population used here may not
reflect the findings in the general community, and the
results should be further confirmed with several longitudinal
studies.
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